Repligen Corporation (RGEN)
Nasdaq: RGEN · Biological Products, (No Diagnostic Substances) · Waltham, MA · filing with the SEC since 1995
Grade5.4
◀ Past 6.3● Present 6.4▶ Future 4.1
Filings
259 filings since 2017 beside 415 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Mar 1, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 27 days after the quarter ended. The proxy statement was last filed Apr 2, 2026.
Filings a yearinsider forms included
6066655764997082
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Sep 15, 2026.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest Sep 18, 2024.SEC letters: 6 in the last 36 months, the newest Sep 10, 2025.A late-filing notice, Form NT 10-K, filed Mar 3, 2025.A late-filing notice, Form NT 10-Q, filed Nov 12, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 6, 2026
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Oct 30, 2026
8-K items 3.02, 8.01, 9.01
Shares sold without registration; Other event · Current report
Oct 29, 2026
Oct 6, 2026
8-K items 2.01, 7.01, 9.01
Purchase or sale of a business completed; Investor disclosure (Regulation FD) · Current report
Jul 22, 2026
8-K items 1.01, 2.02, 7.01, 8.01, 9.01
Major agreement signed; Results released; Investor disclosure (Regulation FD); Other event · Current report
Jul 21, 2026
Jan 6, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
40 of 259 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.